Where does OCRA's clinical trial data come from?

OCRA indexes clinical trials from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Trials are matched to diseases, investigators, and funded research tracked across the platform.

How do I find clinical trials for ovarian cancer?

Search by condition, treatment type, trial phase, or NCT identifier. Each trial page shows current status, eligibility criteria, study locations, and a direct link to the ClinicalTrials.gov source record.

How often is clinical trial data updated?

Trial data is refreshed through periodic ingestion from the ClinicalTrials.gov v2 API. Status changes, new enrollments, and newly registered trials are captured during each update cycle.

Multimedia Aid for Genetic Testing in Gynecologic Oncology

NCT07084168RecruitingNAINTERVENTIONAL

Summary

This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted. Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.

Key Facts

Lead Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

Start Date

2024-10-10

Completion Date

2026-10-30

Study Type

INTERVENTIONAL

Official Title

Multimedia Aid for Genetic Testing in Gynecologic Oncology

Interventions

Educational videosSurvey

Conditions

Ovary CancerEndometrial Cancer

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.

* Reviewed informed consent to participate in the study.
* Subject is willing and able to comply with study procedures based on the judgment of the investigator.
* Age ≥ 18 years at the time of consent.
* Diagnosis of ovarian cancer or endometrial cancer
* Eligible for genetic testing
* English or Spanish is the primary language

Exclusion Criteria:

* Previously completed genetic testing
* Did not receive initial cancer-directed treatment at study site

Outcome Measures

Primary Outcomes

Proportion of genetic testing

Proportion of eligible patients undergoing any genetic testing before and after the implementation of educational videos.

Time frame: Baseline

Secondary Outcomes

Overall rates of genetic testing

Overall rates of genetic testing before and after the implementation of multimedia videos for patient education.

Time frame: Baseline

Patient satisfaction

Total scores on patient satisfaction will be measured by a survey. Items are rated by patients on a Likert scale from 1 to 5. Higher scores represent better satisfaction.

Time frame: Baseline

Locations

Univeristy of North Carolina at Chapel Hill, Chapel Hill, United States